Cannara Biotech (TSXV:LOVE) 1-Year Share Buyback Ratio : 0.00% (As of Nov. 2024 )

View and export this data going back to 2019. Start your Free Trial

What is Cannara Biotech 1-Year Share Buyback Ratio?

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

1-Year Share Buyback Ratio measures the proportion of a company's outstanding shares repurchased over the past year, calculated as the percentage change in shares outstanding from the previous year to the current year. A positive ratio may indicates share buybacks over the period, while a zero or negative ratio suggests no buybacks or potential share issuance. Cannara Biotech's current 1-Year Share Buyback Ratio was 0.00%.

TSXV:LOVE's 1-Year Share Buyback Ratio is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: -1.9
* Ranked among companies with meaningful 1-Year Share Buyback Ratio only.

Competitive Comparison of Cannara Biotech's 1-Year Share Buyback Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Cannara Biotech's 1-Year Share Buyback Ratio, along with its competitors' market caps and 1-Year Share Buyback Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cannara Biotech's 1-Year Share Buyback Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cannara Biotech's 1-Year Share Buyback Ratio distribution charts can be found below:

* The bar in red indicates where Cannara Biotech's 1-Year Share Buyback Ratio falls into.

Save Embed

;

Save Embed

;

Cannara Biotech 1-Year Share Buyback Ratio Calculation

Cannara Biotech's 1-Year Share Buyback Ratio for the quarter that ended in Nov. 2024 is calculated as

1-Year Share Buyback Ratio	=	(Shares Outstanding (EOP) (Nov. 2023 )	-	Shares Outstanding (EOP) (Nov. 2024 ))	/	Shares Outstanding (EOP) (Nov. 2023 )
	=	(90.024	-	90.019)	/	90.024
	=	0.0%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cannara Biotech (TSXV:LOVE) 1-Year Share Buyback Ratio Explanation

A positive ratio may indicates share buybacks over the period, while a zero or negative ratio suggests no buybacks or potential share issuance.

Be Aware

Investors usually like share buybacks. But as pointed by Warren Buffett, only if a company buys back shares at the prices below the stock's intrinsic value, it rewards remaining shareholders. If a company buys its overvalued stocks back, it destroys shareholder value.

Cannara Biotech 1-Year Share Buyback Ratio Related Terms

Cannara Biotech Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cannara Biotech Inc (TSXV:LOVE) » Definitions » 1-Year Share Buyback Ratio

Comparable Companies

Traded in Other Exchanges

LOVFF:USA 8CB0:Germany

Address

1055 West Georgia Street, Suite 2050, Vancouver, BC, CAN, V6E 3P3

Website

http://www.cannara.ca

Cannara Biotech Inc is a vertically integrated producer of premium-grade cannabis and cannabis-derivative products for Canadian markets. The company owns two mega Quebec-based facilities. The company operates in in two segments; Indoor cannabis operations segment which includes the cultivation, processing and sale of dried cannabis and cannabis derivatives for the Canadian market and the Real estate operations segment related to the Farnham and Valleyfield building. Majority of the revenue for the company is generated from its Cannabis operations segment. .

Executives

Nicholas Sosiak	Senior Officer
Donald John Olds	Director
Olymbec Investments Inc.	10% Security Holder
Derek Elan Stern	Director
Scott Carroll	Director or Senior Officer of Insider or Subsidiary (other than in 4,5,6)
Zohar Krivorot	Director, Senior Officer
Brian Sherman	Senior Officer
Avi Krivorot	Director or Senior Officer of Insider or Subsidiary (other than in 4,5,6)
Lennie Ryer	Senior Officer
Jack M. Kay	Director
Donal Carroll	Director or Senior Officer of 10% Security Holder